TCL Archive Conferees Set $1.991 Bil. NCI Budget, Ax Earmark For Breast Cancer, But Find $210 Mil. In Defense October 9, 1992
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Ohio Plans To Build Four New Cancer Centers With $140 Million Bond Issue If Voters Approve February 21, 1975
TCL Archive NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted March 19, 1976
